Reflections on dry eye syndrome treatment: therapeutic role of blood products

VJ Drew, CL Tseng, J Seghatchian, T Burnouf - Frontiers in medicine, 2018 - frontiersin.org
Dry eye syndrome (DES) is a multifactorial, frequent, pathology characterized by deficient
tear production or increased evaporation of tears and associated with ocular surface …

SARS‐CoV‐2 ORF7a blocked autophagy flux by intervening in the fusion between autophagosome and lysosome to promote viral infection and pathogenesis

S Li, X Li, H Liang, K Yu, J Zhai, M Xue… - Journal of Medical …, 2023 - Wiley Online Library
Abstract The coronavirus disease 2019 (COVID‐19) continues to pose a major threat to
public health worldwide. Although many studies have clarified the severe acute respiratory …

Selective pharmacologic therapies for dry eye disease treatment: efficacy, tolerability, and safety data review from preclinical studies and pivotal trials

B Shen Lee, M Toyos, P Karpecki, J Schiffbauer… - Ophthalmology and …, 2022 - Springer
Keratoconjunctivitis sicca, also known as dry eye disease (DED), is a prevalent,
multifactorial disease associated with compromised ocular lubrication, ocular surface …

Lifitegrast: a novel drug for treatment of dry eye disease

A Abidi, P Shukla, A Ahmad - Journal of Pharmacology and …, 2016 - journals.sagepub.com
Dry eye disease (DED) is an inflammatory disorder of ocular surfaces leading to severe
disability, especially in the elderly age group. The mainstay of therapy includes artificial …

Anti-inflammatory and antioxidative effects of gallic acid on experimental dry eye: in vitro and in vivo studies

K Li, Q Gong, B Lu, K Huang, Y Tong, TE Mutsvene… - Eye and Vision, 2023 - Springer
Background To investigate the anti-inflammatory and antioxidative effects of gallic acid (GA)
on human corneal epithelial cells (HCECs) and RAW264. 7 macrophages as well as its …

[HTML][HTML] Recent progress of nanomedicine in managing dry eye disease

Z Lv, S Li, G Zeng, K Yao, H Han - Advances in Ophthalmology Practice and …, 2024 - Elsevier
Background Dry eye disease (DED) is a commonly reported ocular complaint that has
garnered significant attention in recent research. The global occurrence of DED ranges from …

Topical quercetin and resveratrol protect the ocular surface in experimental dry eye disease

A Abengózar-Vela, CS Schaumburg… - Ocular Immunology …, 2019 - Taylor & Francis
Purpose: To determine the anti-inflammatory effect of quercetin (QCT), resveratrol (RES),
and their combination in a dry eye disease (DED) model. Methods: 0.01% QCT, 0.1% RES …

The use of topical corticosteroids for treatment of dry eye syndrome

CA Cutolo, S Barabino, C Bonzano… - Ocular immunology and …, 2019 - Taylor & Francis
Dry eye disease (DED) is a multifactorial disease that results in symptoms of discomfort,
visual disturbance, and damage to the ocular surface. Because chronic inflammation plays …

Analysis of tear inflammatory molecules and clinical correlations in evaporative dry eye disease caused by meibomian gland dysfunction

X Wu, X Chen, Y Ma, X Lin, X Yu, S He, C Luo… - International …, 2020 - Springer
Purpose To compare the levels of inflammatory molecules in tear samples between patients
with meibomian gland dysfunction (MGD)-related evaporative dry eye (EDE) and healthy …

The effect of lifitegrast on refractive accuracy and symptoms in dry eye patients undergoing cataract surgery

J Hovanesian, A Epitropoulos… - Clinical …, 2020 - Taylor & Francis
Purpose To determine the effect of lifitegrast ophthalmic solution 5% on improving the tear
film, biometry/keratometry, and refractive accuracy for dry eye patients scheduled for cataract …